ABSTRACT
OBJECTIVE: We present our data comparing retrospectively the efficacy of abiraterone and cabazitaxel in patients who progress after docetaxel treatment. PATIENTS AND METHODS: The study included 56 patients diagnosed with hormone‑refractory metastatic prostate cancer who were previously treated with abiraterone therapy at four oncology centers in Turkey. RESULTS: With abiraterone, the patients had a median progression‑free survival (PFS) of 5.9 months (95% confidence interval (CI) for hazard ratio (HR) (4.4–7.4)) and an overall survival of 13.4 months (95% CI for HR (5.5–21.3)). When we compared the disease‑free survival (DFS) of reference patients treated with cabazitaxel as a second‑line treatment with those receiving second‑line abiraterone therapy, there was no significant difference. (PFS = 5.9 months with cabazitaxel vs. 6.7 months with abiraterone, P = 0.213). CONCLUSION: This study has shown that in our experience abiraterone acetate is an effective agent in metastatic castration‑resistant prostate cancer (mCRPC) regardless of the line of treatment.
ABSTRACT
The venomous Levantine viper, Macrovipera lebetina lebetina is endemic to Cyprus. The objective of this study was to investigate in vitro cytotoxicity, in vivo lethality, and antivenom production followed by a re-immunization schedule in mice against Macrovipera lebetina lebetina venom. The LD50 value was estimated as 7.58 mg/kg within 24 hours by different venom doses administrated intraperitoneally in mice. Freund's complete and incomplete adjuvants were used for first and second immunization of mice in antivenom production. A cell-based assay was performed to determine the effects of Macrovipera lebetina lebetina venom and antivenom neutralizing potency on L929 cell viability. The snake venom toxicity and cytotoxicity were examined and comparison of results showed good correlation, the LD50 value was tenfold higher than the IC50 value. The IC50 value was 0.62 ± 0.18 mL after 48 hours treatment while the calculated value was 1.62 ± 0.25 mL for the culture media totally refreshed after two hours treatment with venom. The in vitro efficacy of antivenom against Macrovipera lebetina lebetina venom was found to be low. This is the first report that describes the in vivo and in vitro toxic effects of Macrovipera lebetina lebetina venom and antivenom production against this species.(AU)
Subject(s)
Snake Venoms , In Vitro Techniques , Antivenins , Toxicity , ViperidaeABSTRACT
The aim of this study was to investigate gamma radiation-induced oxidative damage in erythrocytes after 201Tl myocardial perfusion scintigraphy. Twenty patients (8 women and 12 men) who performed 201Tl myocardial perfusion scintigraphy were included in this study. The blood samples were taken from patients just before, 1 hour after and three hours after injection of the radiopharmaceutical. Malon-dialdehyde (MDA) and antioxidant enzymes such as glutathione peroxidase (GPX), superoxide dismutase (SOD) and catalase (CAT) levels were measured to evaluate the gamma radiation induced oxidative damage. The enzyme activities of SOD, GPX and CAT were decreased 1 hour after (p = 0.042, p = 0. 697 and p = 0.653 respectively) and 3 hours after (p = 0.003, p = 0. 573 and p = 0.002 respectively) injection of the radiopharmaceutical. Malondialdehyde levels were increased 1 hour after (p = 0.10) and 3 hours after (p = 0.47) injection of the radiopharmaceutical. In this study, we found that radiation due to 201Tl myocardial perfusion scintigraphy decreased the erythrocyte antioxidant levels and increased MDA levels.
El objetivo de este estudio fue investigar el daño oxidativo inducido por radiaciones gamma, sobre los eritrocitos luego de realizada una escintigrafía de perfusión miocárdica 201Tl. Veinte pacientes (8 mujeres y 12 hombres) a quienes se les realizó escintigrafía por perfusión miocárdica 201Tl, fueron incluidos en este estudio. Las muestras de sangre fueron tomadas de los pacientes antes, 1 hora más tarde, y tres horas después de inyectar el radiofármaco. Se midieron los niveles del malondialdehido (MDA) y las enzimas antioxidantes tales como la glutationa peroxidasa (GPX), superóxido dismutasa (SOD), y la catalasa (CAT), a fin de evaluar el daño oxidativo inducido por la radiación gamma. Las actividades de las enzimas SOD, GPX y CAT fueron disminuidas 1 horas después (p = 0.042, p = 0. 697 y p = 0.653 respectivamente) y tres horas (p = 0.003, p = 0. 573 y p = 0.002 respectivamente) tras la inyección del radiofármaco. Los niveles de malondialdehido fueron aumentados 1 hora después (p = 0.10) y tres horas después (p = 0.47) de la inyección del radiofármaco. En este estudio, hallamos que la radiación a causa de la escintigrafía de perfusión miocárdica 201Tl disminuyó los niveles antioxidantes del eritrocito y aumentó los niveles de MDA.
Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Coronary Disease , Erythrocytes/radiation effects , Radiopharmaceuticals , Thallium Radioisotopes , Analysis of Variance , Catalase/blood , Coronary Disease/enzymology , Glutathione Peroxidase/blood , Lipid Peroxidation , Malondialdehyde/blood , Oxidative Stress , Superoxide Dismutase/bloodABSTRACT
BACKGROUND: Many authors have claimed that hyperthyroidism protects against thyroid cancer and believed that the incidence of malignancy is lower in patients with toxic multinodular goiter (TMG) than in those with non-toxic multinodular goiter. But in recent studies, it was reported that the incidence of malignancy with TMG is not as low as previously thought. AIM: To compare the thyroid cancer incidence in patients with toxic and non-toxic multinodular goiter. SETTINGS AND DESIGN: Histology reports of patients treated surgically with a preoperative diagnosis of toxic and non-toxic multinodular goiter were reviewed to identify the thyroid cancer incidence. Patients having a history of neck irradiation or radioactive iodine therapy were excluded from the study. MATERIALS AND METHODS: We reviewed 294 patients operated between 2001-2005 from toxic and non-toxic multinodular goiter. One hundred and twenty-four of them were toxic and 170 were non-toxic. Hyperthyroidism was diagnosed by elevated tri-iodothyroinine / thyroxine ratios and low thyroid-stimulating hormone with clinical signs and symptoms. All patients were evaluated with ultrasonography and scintigraphy and fine needle aspiration biopsy. STATISTICAL ANALYSIS USED: Significance of the various parameters was calculated by using ANOVA test. RESULTS: The incidence of malignancy was 9% in the toxic and 10.58% in the non-toxic multinodular goiter group. Any significant difference in the incidence of cancer and tumor size between the two groups could not be detected. CONCLUSIONS: The incidence of malignancy in toxic multinodular goiter is not very low as thought earlier and is nearly the same in non-toxic multinodular goiter.